FDA Authorizes Emergency Use Of Over-The-Counter, At-Home Rapid Test For Coronavirus

New York Times: New At-Home Covid Test Gets Green Light From FDA
“The Food and Drug Administration on Tuesday issued an emergency authorization for the country’s first coronavirus test that can run from start to finish at home without the need for a prescription. People as young as 2 years old are cleared to use the test, which takes just 15 to 20 minutes to deliver a result. Unlike many similar products, which are only supposed to be used by people with symptoms of Covid-19, this test is authorized for people with or without symptoms. The test, developed by the Australian company Ellume, detects bits of coronavirus proteins called antigens…” (Wu, 12/15).

Additional coverage of the FDA’s authorization of the test is available from Axios, CNN, The Hill, NPR, POLITICO, USA TODAY, and Washington Post.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.